Compare ALEMBIC PHARMA with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA VENUS REMEDIES ALEMBIC PHARMA/
VENUS REMEDIES
 
P/E (TTM) x 16.2 -10.8 - View Chart
P/BV x 6.4 0.7 892.8% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ALEMBIC PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
VENUS REMEDIES
Mar-18
ALEMBIC PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs664126 527.4%   
Low Rs41261 675.0%   
Sales per share (Unadj.) Rs208.7301.8 69.2%  
Earnings per share (Unadj.) Rs31.0-24.9 -124.6%  
Cash flow per share (Unadj.) Rs37.12.5 1,458.4%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.2293.3 49.2%  
Shares outstanding (eoy) m188.5212.34 1,527.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.60.3 832.3%   
Avg P/E ratio x17.4-3.8 -461.8%  
P/CF ratio (eoy) x14.536.7 39.5%  
Price / Book Value ratio x3.70.3 1,170.6%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,4611,154 8,793.8%   
No. of employees `000NA0.9 0.0%   
Total wages/salary Rs m7,467393 1,899.5%   
Avg. sales/employee Rs ThNM4,026.1-  
Avg. wages/employee Rs ThNM425.0-  
Avg. net profit/employee Rs ThNM-331.8-  
INCOME DATA
Net Sales Rs m39,3473,724 1,056.5%  
Other income Rs m9423 416.9%   
Total revenues Rs m39,4413,747 1,052.7%   
Gross profit Rs m8,736395 2,212.7%  
Depreciation Rs m1,152338 340.6%   
Interest Rs m184354 52.0%   
Profit before tax Rs m7,493-275 -2,721.8%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,56832 4,960.4%   
Profit after tax Rs m5,844-307 -1,904.1%  
Gross profit margin %22.210.6 209.4%  
Effective tax rate %20.9-11.5 -182.2%   
Net profit margin %14.9-8.2 -180.2%  
BALANCE SHEET DATA
Current assets Rs m19,5772,638 742.2%   
Current liabilities Rs m14,8962,305 646.4%   
Net working cap to sales %11.98.9 133.0%  
Current ratio x1.31.1 114.8%  
Inventory Days Days90135 66.3%  
Debtors Days Days4546 97.9%  
Net fixed assets Rs m27,0974,871 556.3%   
Share capital Rs m377123 305.5%   
"Free" reserves Rs m26,8113,496 767.0%   
Net worth Rs m27,1883,619 751.2%   
Long term debt Rs m4,9931,374 363.3%   
Total assets Rs m47,7787,509 636.3%  
Interest coverage x41.70.2 18,702.5%   
Debt to equity ratio x0.20.4 48.4%  
Sales to assets ratio x0.80.5 166.0%   
Return on assets %12.60.6 1,998.5%  
Return on equity %21.5-8.5 -253.5%  
Return on capital %23.61.6 1,491.8%  
Exports to sales %00-   
Imports to sales %013.9 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA517 0.0%   
Fx inflow Rs m19,4530-   
Fx outflow Rs m6,065517 1,174.2%   
Net fx Rs m13,388-517 -2,592.0%   
CASH FLOW
From Operations Rs m8,120514 1,578.5%  
From Investments Rs m-7,556-123 6,138.1%  
From Financial Activity Rs m590-387 -152.5%  
Net Cashflow Rs m1,1534 27,459.5%  

Share Holding

Indian Promoters % 74.1 32.9 225.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.2 1,611.1%  
FIIs % 9.1 0.6 1,569.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 66.4 20.9%  
Shareholders   49,328 20,121 245.2%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   ORCHID PHARMA  CIPLA  TORRENT PHARMA  SUVEN LIFE SCIENCES  WYETH  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 500 Points; Grasim Industries & HDFC Bank Top Gainers(09:30 am)

Asian share markets are trading on a mixed note tracking a mixed Wall Street session following a big downturn in tech shares.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

Charge Your Portfolio with this Smallcap Proxy Play on India's EV Revolution(Profit Hunter)

Mar 5, 2021

This could be the biggest wealth creator of the decade.

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Mar 9, 2021 09:58 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS